Ya-bo Jiang
225 Changhai Road
Shanghai, 200438, China
Shanghai, 200438, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Optimal duration of adjuvant targeted-immunotherapy in patients with initially unresectable hepatocellular carcinoma with portal vein tumor thrombus following successful conversion therapy.
Journal: The oncologist
Published: December 01, 2025
Postoperative adjuvant aspirin for patients with hepatitis B virus-related hepatocellular carcinoma and portal vein tumor thrombus: An open-label, randomized controlled trial.
Journal: Heliyon
Published: December 14, 2022
CpG-binding protein CFP1 promotes ovarian cancer cell proliferation by regulating BST2 transcription.
Journal: Cancer gene therapy
Published: December 16, 2021
Scinderin suppresses cell proliferation and predicts the poor prognosis of hepatocellular carcinoma.
Scinderin suppresses cell proliferation and predicts the poor prognosis of hepatocellular carcinoma.
Journal: Oncology letters
Published: March 19, 2019
Thrombocytopenia: A prognostic factor for hepatocellular carcinoma patients with portal vein tumor thrombus after hepatectomy.
Journal: Journal of gastroenterology and hepatology
Published: September 23, 2018
A serological scoring system to predict lymph node metastasis in patients with hepatocellular carcinoma.
Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association
Published: January 15, 2018
PRMT1 Promoted HCC Growth and Metastasis In Vitro and In Vivo via Activating the STAT3 Signalling Pathway.
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: December 29, 2017
FABP4 suppresses proliferation and invasion of hepatocellular carcinoma cells and predicts a poor prognosis for hepatocellular carcinoma.
Journal: Cancer medicine
Published: December 10, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026